253 related articles for article (PubMed ID: 27557521)
1. Activation of HERV-K Env protein is essential for tumorigenesis and metastasis of breast cancer cells.
Zhou F; Li M; Wei Y; Lin K; Lu Y; Shen J; Johanning GL; Wang-Johanning F
Oncotarget; 2016 Dec; 7(51):84093-84117. PubMed ID: 27557521
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral
Li M; Radvanyi L; Yin B; Rycaj K; Li J; Chivukula R; Lin K; Lu Y; Shen J; Chang DZ; Li D; Johanning GL; Wang-Johanning F
Clin Cancer Res; 2017 Oct; 23(19):5892-5911. PubMed ID: 28679769
[No Abstract] [Full Text] [Related]
3. Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors.
Wang-Johanning F; Rycaj K; Plummer JB; Li M; Yin B; Frerich K; Garza JG; Shen J; Lin K; Yan P; Glynn SA; Dorsey TH; Hunt KK; Ambs S; Johanning GL
J Natl Cancer Inst; 2012 Feb; 104(3):189-210. PubMed ID: 22247020
[TBL] [Abstract][Full Text] [Related]
4. Chimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of Ras.
Zhou F; Krishnamurthy J; Wei Y; Li M; Hunt K; Johanning GL; Cooper LJ; Wang-Johanning F
Oncoimmunology; 2015 Nov; 4(11):e1047582. PubMed ID: 26451325
[TBL] [Abstract][Full Text] [Related]
5. Human Endogenous Retrovirus (HERV)-K
Ko EJ; Ock MS; Choi YH; Iovanna JL; Mun S; Han K; Kim HS; Cha HJ
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920455
[TBL] [Abstract][Full Text] [Related]
6. Effect of human endogenous retrovirus-K env gene knockout on proliferation of ovarian cancer cells.
Ko EJ; Kim ET; Kim H; Lee CM; Koh SB; Eo WK; Kim H; Oh YL; Ock MS; Kim KH; Cha HJ
Genes Genomics; 2022 Sep; 44(9):1091-1097. PubMed ID: 35802343
[TBL] [Abstract][Full Text] [Related]
7. A human endogenous retrovirus-derived gene that can contribute to oncogenesis by activating the ERK pathway and inducing migration and invasion.
Lemaître C; Tsang J; Bireau C; Heidmann T; Dewannieux M
PLoS Pathog; 2017 Jun; 13(6):e1006451. PubMed ID: 28651004
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of HERV-K env gene expression and splicing in human breast cancer.
Wang-Johanning F; Frost AR; Jian B; Epp L; Lu DW; Johanning GL
Oncogene; 2003 Mar; 22(10):1528-35. PubMed ID: 12629516
[TBL] [Abstract][Full Text] [Related]
9. Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients.
Wang-Johanning F; Radvanyi L; Rycaj K; Plummer JB; Yan P; Sastry KJ; Piyathilake CJ; Hunt KK; Johanning GL
Cancer Res; 2008 Jul; 68(14):5869-77. PubMed ID: 18632641
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cells.
Rycaj K; Plummer JB; Yin B; Li M; Garza J; Radvanyi L; Ramondetta LM; Lin K; Johanning GL; Tang DG; Wang-Johanning F
Clin Cancer Res; 2015 Jan; 21(2):471-83. PubMed ID: 25370465
[TBL] [Abstract][Full Text] [Related]
11. Expression of human endogenous retrovirus k envelope transcripts in human breast cancer.
Wang-Johanning F; Frost AR; Johanning GL; Khazaeli MB; LoBuglio AF; Shaw DR; Strong TV
Clin Cancer Res; 2001 Jun; 7(6):1553-60. PubMed ID: 11410490
[TBL] [Abstract][Full Text] [Related]
12. Analysis of KAP1 expression patterns and human endogenous retrovirus Env proteins in ovarian cancer.
Jeon KY; Ko EJ; Oh YL; Kim H; Eo WK; Kim A; Sun HG; Ock MS; Kim KH; Cha HJ
Genes Genomics; 2020 Oct; 42(10):1145-1150. PubMed ID: 32785870
[TBL] [Abstract][Full Text] [Related]
13. Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer.
Wang-Johanning F; Liu J; Rycaj K; Huang M; Tsai K; Rosen DG; Chen DT; Lu DW; Barnhart KF; Johanning GL
Int J Cancer; 2007 Jan; 120(1):81-90. PubMed ID: 17013901
[TBL] [Abstract][Full Text] [Related]
14. Expression of human endogenous retrovirus-K is strongly associated with the basal-like breast cancer phenotype.
Johanning GL; Malouf GG; Zheng X; Esteva FJ; Weinstein JN; Wang-Johanning F; Su X
Sci Rep; 2017 Feb; 7():41960. PubMed ID: 28165048
[TBL] [Abstract][Full Text] [Related]
15. Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on Melanoma.
Krishnamurthy J; Rabinovich BA; Mi T; Switzer KC; Olivares S; Maiti SN; Plummer JB; Singh H; Kumaresan PR; Huls HM; Wang-Johanning F; Cooper LJ
Clin Cancer Res; 2015 Jul; 21(14):3241-51. PubMed ID: 25829402
[TBL] [Abstract][Full Text] [Related]
16. Env gene expression of human endogenous retrovirus-k and human endogenous retrovirus-w in childhood acute leukemia cells.
Januszkiewicz-Lewandowska D; Nowicka K; Rembowska J; Fichna M; Żurawek M; Derwich K; Nowak J
Acta Haematol; 2013; 129(4):232-7. PubMed ID: 23328642
[TBL] [Abstract][Full Text] [Related]
17. Expression of human endogenous retrovirus type K envelope glycoprotein in insect and mammalian cells.
Tönjes RR; Limbach C; Löwer R; Kurth R
J Virol; 1997 Apr; 71(4):2747-56. PubMed ID: 9060628
[TBL] [Abstract][Full Text] [Related]
18. BHLHE40 confers a pro-survival and pro-metastatic phenotype to breast cancer cells by modulating HBEGF secretion.
Sethuraman A; Brown M; Krutilina R; Wu ZH; Seagroves TN; Pfeffer LM; Fan M
Breast Cancer Res; 2018 Oct; 20(1):117. PubMed ID: 30285805
[TBL] [Abstract][Full Text] [Related]
19. Human Endogenous Retrovirus K Rec forms a Regulatory Loop with MITF that Opposes the Progression of Melanoma to an Invasive Stage.
Singh M; Cai H; Bunse M; Feschotte C; Izsvák Z
Viruses; 2020 Nov; 12(11):. PubMed ID: 33202765
[TBL] [Abstract][Full Text] [Related]
20. IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells.
Battula VL; Nguyen K; Sun J; Pitner MK; Yuan B; Bartholomeusz C; Hail N; Andreeff M
Oncotarget; 2017 Jun; 8(23):36936-36949. PubMed ID: 28415808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
